The long-term objective of this project is to investigate the molecular mechanism of neuropathic pain resulting from peripheral nerve injuries. These disorders do not typically respond to conventional analgesics, and represent major problems affecting the quality of daily life of patients. Unfortunately, the molecular mechanisms of neuropathic pain are poorly understood and, as a consequence, there are no specifically targeted, effective pharmacological agents available for neuropathic pain treatment. Our preliminary data indicate a correlation between increased expression, in sensory neurons and spinal cord, of alpha 2 delta calcium channel subunit and neuropathic pain development in a rat model of peripheral nerve injury. This suggests that altered alpha 2 delta calcium channel subunit expression or its modulation to functional calcium channels may underline the neuronal plasticity following peripheral nerve injury, and play a role in neuropathic pain processing. Using molecular, immunohistochemical and pharmacological techniques, this research proposal is designed to test this hypothesis by examining 1) the possible roles of spinal alpha 2 delta subunit expression in neuropathic pain development and 2) the cellular mechanisms of nerve injury-induced alteration in alpha 2 delta subunit expression in spinal cord and sensory neurons.

Agency
National Institute of Health (NIH)
Institute
National Institute of Neurological Disorders and Stroke (NINDS)
Type
Research Project (R01)
Project #
5R01NS040135-03
Application #
6625488
Study Section
Special Emphasis Panel (ZRG1-IFCN-4 (01))
Program Officer
Porter, Linda L
Project Start
2000-12-25
Project End
2003-08-31
Budget Start
2002-12-01
Budget End
2003-08-31
Support Year
3
Fiscal Year
2003
Total Cost
$239,445
Indirect Cost
Name
University of California San Diego
Department
Anesthesiology
Type
Schools of Medicine
DUNS #
804355790
City
La Jolla
State
CA
Country
United States
Zip Code
92093
Park, John; Yu, Yanhui Peter; Zhou, Chun-Yi et al. (2016) Central Mechanisms Mediating Thrombospondin-4-induced Pain States. J Biol Chem 291:13335-48
Zhou, C; Luo, Z D (2015) Nerve injury-induced calcium channel alpha-2-delta-1 protein dysregulation leads to increased pre-synaptic excitatory input into deep dorsal horn neurons and neuropathic allodynia. Eur J Pain 19:1267-76
Nguyen, David; Deng, Ping; Matthews, Elizabeth A et al. (2009) Enhanced pre-synaptic glutamate release in deep-dorsal horn contributes to calcium channel alpha-2-delta-1 protein-mediated spinal sensitization and behavioral hypersensitivity. Mol Pain 5:6
Eroglu, Cagla; Allen, Nicola J; Susman, Michael W et al. (2009) Gabapentin receptor alpha2delta-1 is a neuronal thrombospondin receptor responsible for excitatory CNS synaptogenesis. Cell 139:380-92
Boroujerdi, Amin; Kim, Hee Kee; Lyu, Yeoung Su et al. (2008) Injury discharges regulate calcium channel alpha-2-delta-1 subunit upregulation in the dorsal horn that contributes to initiation of neuropathic pain. Pain 139:358-66
Xiao, W; Boroujerdi, A; Bennett, G J et al. (2007) Chemotherapy-evoked painful peripheral neuropathy: analgesic effects of gabapentin and effects on expression of the alpha-2-delta type-1 calcium channel subunit. Neuroscience 144:714-20
Li, Chun-Ying; Zhang, Xiu-Lin; Matthews, Elizabeth A et al. (2006) Calcium channel alpha2delta1 subunit mediates spinal hyperexcitability in pain modulation. Pain 125:20-34
Li, Chun-Ying; Song, Yan-Hua; Higuera, Emiliano S et al. (2004) Spinal dorsal horn calcium channel alpha2delta-1 subunit upregulation contributes to peripheral nerve injury-induced tactile allodynia. J Neurosci 24:8494-9
Valder, Carolina R; Liu, Jan-Jan; Song, Yan-Hua et al. (2003) Coupling gene chip analyses and rat genetic variances in identifying potential target genes that may contribute to neuropathic allodynia development. J Neurochem 87:560-73
Luo, Z D; Calcutt, N A; Higuera, E S et al. (2002) Injury type-specific calcium channel alpha 2 delta-1 subunit up-regulation in rat neuropathic pain models correlates with antiallodynic effects of gabapentin. J Pharmacol Exp Ther 303:1199-205